Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole sodium bicarbonate capsules for reflux esophagitis
ChiCTR2300079295Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lansoprazole + sodium bicarbonate in erosive esophagitis (EE) (3 arms), sponsored by Renji Hospital. Primary endpoints: First day of complete heartburn relief, Change in serum gastrin at week 4 and 1 more. Started Dec 2023; status: recruiting.
02
Drugs
lansoprazole + sodium bicarbonate
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on ChiCTR2300079295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079295.